Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis

Genes and Development

Volumn 25, Issue 14, 2011, Pages 1510-1527

  Wei, Huijun ^a   Wei, Shuang ^a   Gan, Boyi ^a,b   Peng, Xu ^a,c   Zou, Weiping ^a   Guan, Jun Lin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Autophagy; Breast cancer; Conditional knockout; FIP200; Mouse models

Indexed keywords

AUTOPHAGY PROTEIN 5; AUTOPHAGY PROTEIN 7; BECLIN 1; CYCLIN D1; FAK FAMILY INTERACTING PROTEIN 200KDA; INTERFERON; PROTEIN; PROTEIN P62; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; BREAST TUMOR; CANCER INHIBITION; CARCINOGENESIS; CELL ORGANELLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE DELETION; GENE INACTIVATION; GLYCOLYSIS; IN VIVO STUDY; KNOCKOUT MOUSE; LYSOSOME; MITOCHONDRION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; TUMOR CELL;

ANIMALS; AUTOPHAGY; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

MUS;

EID: 79960401862     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.2051011     Document Type: Article

References (103)

1. Abbi S, Ueda H, Zheng C, Cooper LA, Zhao J, Christopher R, Guan JL. 2002. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell 13: 3178-3191.
2. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. 2007. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 14: 500-510.
3. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, Levine B. 1999. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59-65.
4. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. 2007. Autophagy inhibition enhances therapy-induced apoptosis in a Mycinduced model of lymphoma. J Clin Invest 117: 326-336.
5. Araki Y, Wang Z, Zang C, Wood WH III, Schones D, Cui K, Roh TY, Lhotsky B, Wersto RP, PengW, et al. 2009. Genome-wide analysis of histone methylation reveals chromatin statebased regulation of gene transcription and function of memory CD8+ T cells. Immunity 30: 912-925.
6. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. 2000. Gene Ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
7. Behrends C, Sowa ME, Gygi SP, Harper JW. 2010. Network organization of the human autophagy system. Nature 466: 68-76.
8. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6: 975-990.
9. Bui JD, Schreiber RD. 2007. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol 19: 203-208.
10. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456: 259-263.
11. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. 2010. Virusplus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141: 1135-1145.
12. Chano T, Ikegawa S, Kontani K, Okabe H, Baldini N, Saeki Y. 2002a. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene 21: 1295-1298.
13. Chano T, Kontani K, Teramoto K, Okabe H, Ikegawa S. 2002b. Truncating mutations of RB1CC1 in human breast cancer. Nat Genet 31: 285-288.
14. Critchley-Thorne RJ, Simons DL, Yan N, Miyahira AK, Dirbas FM, Johnson DL, Swetter SM, Carlson RW, Fisher GA, Koong A, et al. 2009. Impaired interferon signaling is a common immune defect in human cancer. Proc Natl Acad Sci 106: 9010-9015.
15. Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. 2010. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 6: 322-329.
16. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, et al. 2006. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64.
17. Deng Q, Li Y, Tedesco D, Liao R, Fuhrmann G, Sun P. 2005. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins. Cancer Res 65: 8298-8307.
18. De Palma M, Mazzieri R, Politi LS, Pucci F, Zonari E, Sitia G, Mazzoleni S, Moi D, Venneri MA, Indraccolo S, et al. 2008. Tumor-targeted interferon-a delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 14: 299-311.
19. Dong C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
20. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 3: 991-998.
21. Dunn GP, Old LJ, Schreiber RD. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148.
22. Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848.
23. Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, et al. 2008. Autophagy is important in islet homeostasis and compensatory increase of b cell mass in response to high-fat diet. Cell Metab 8: 325-332.
24. Farber JM. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61: 246-257.
25. Finn OJ. 2008. Cancer immunology. N Engl J Med 358: 2704-2715.
26. Frigerio S, Junt T, Lu B, Gerard C, Zumsteg U, Hollander GA, Piali L. 2002. b Cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 8: 1414-1420.
27. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
28. Gan B, Guan JL. 2008. FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal 20: 787-794.
29. Gan B, Melkoumian ZK, Wu X, Guan KL, Guan JL. 2005. Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control. J Cell Biol 170: 379-389.
30. Gan B, Peng X, Nagy T, Alcaraz A, Gu H, Guan JL. 2006. Role of FIP200 in cardiac and liver development and its regulation of TNFa and TSC-mTOR signaling pathways. J Cell Biol 175: 121-133.
31. Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X. 2009. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284: 12297-12305.
32. Gonzalez-Polo RA, Niso-Santano M, Ortiz-Ortiz MA, Gomez-Martin A, Moran JM, Garcia-Rubio L, Francisco-Morcillo J, Zaragoza C, Soler G, Fuentes JM. 2007. Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci 97: 448-458.
33. Gooch JL, Herrera RE, Yee D. 2000. The role of p21 in interferon g-mediated growth inhibition of human breast cancer cells. Cell Growth Differ 11: 335-342.
34. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, et al. 2011. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
35. Guy CT, Cardiff RD, Muller WJ. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
36. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
37. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
38. Hara T, Mizushima N. 2009. Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy 5: 85-87.
39. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889.
40. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL, Mizushima N. 2008. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 181: 497-510.
41. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al. 2009. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20: 1981-1991.
42. Huang J, Manning BD. 2009. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37: 217-222.
43. Jounai N, Takeshita F, Kobiyama K, Sawano A, Miyawaki A, Xin KQ, Ishii KJ, Kawai T, Akira S, Suzuki K, et al. 2007. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci 104: 14050-14055.
44. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH. 2009. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20: 1992-2003.
45. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, White E. 2007. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21: 1621-1635.
46. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, Schwartzman JD, Luster AD. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
47. Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. 2007. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 450: 903-907.
48. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J, Mizushima N, Ohsumi Y, Uchiyama Y, et al. 2005. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 169: 425-434.
49. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, et al. 2006. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
50. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, et al. 2007. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163.
51. Kroemer G, Marino G, Levine B. 2010. Autophagy and the integrated stress response. Mol Cell 40: 280-293.
52. Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W. 2007a. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 179: 1423-1426.
53. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. 2007b. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178: 6730-6733.
54. Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, et al. 2009. Phenotype, distribution, generation, functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114: 1141-1149.
55. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132: 27-42.
56. Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity-+ and inflammation. Nature 469: 323-335.
57. Liang C, Jung JU. 2010. Autophagy genes as tumor suppressors. Curr Opin Cell Biol 22: 226-233.
58. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. 1999. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676.
59. Liang CC, Wang C, Peng X, Gan B, Guan JL. 2010. Neuralspecific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J Biol Chem 285: 3499-3509.
60. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163: 2113-2126.
61. Liu F, Lee JY, Wei H, Tanabe O, Engel JD, Morrison SJ, Guan JL. 2010. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 116: 4806-4814.
62. Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, Debnath J. 2011. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22: 165-178.
63. Loeser S, Loser K, Bijker MS, Rangachari M, van der Burg SH, Wada T, Beissert S, Melief CJ, Penninger JM. 2007. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J Exp Med 204: 879-891.
64. Luo J, Solimini NL, Elledge SJ. 2009. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136: 823-837.
65. Luo M, Fan H, Nagy T, Wei H, Wang C, Liu S, Wicha MS, Guan JL. 2009. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res 69: 466-474.
66. Martin N, Schwamborn K, Urlaub H, Gan B, Guan JL, Dejean A. 2008. Spatial interplay between PIASy and FIP200 in the regulation of signal transduction and transcriptional activity. Mol Cell Biol 28: 2771-2781.
67. Mathew R, Karantza-Wadsworth V, White E. 2007. Role of autophagy in cancer. Nat Rev Cancer 7: 961-967.
68. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al. 2009. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075.
69. Melkoumian ZK, Peng X, Gan B, Wu X, Guan JL. 2005. Mechanism of cell cycle regulation by FIP200 in human breast cancer cells. Cancer Res 65: 6676-6684.
70. Mizushima N. 2007. Autophagy: process and function. Genes Dev 21: 2861-2873.
71. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. 2008. Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075.
72. Mortensen M, Ferguson DJ, Edelmann M, Kessler B, Morten KJ, Komatsu M, Simon AK. 2010. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci 107: 832-837.
73. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et al. 2007. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13: 619-624.
74. Nishikawa T, Tsuno NH, Okaji Y, Shuno Y, Sasaki K, Hongo K, Sunami E, Kitayama J, Takahashi K, Nagawa H. 2010. Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol 17: 592-602.
75. Platanias LC. 2005. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386.
76. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820.
77. Rabinowitz JD, White E. 2010. Autophagy and metabolism. Science 330: 1344-1348.
78. Roy S, Debnath J. 2010. Autophagy and tumorigenesis. Semin Immunopathol 32: 383-396.
79. Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, Omori H, Noda T, Yamamoto N, Komatsu M, et al. 2008. Loss of the autophagy protein Atg16L1 enhances endotoxininduced IL-1b production. Nature 456: 264-268.
80. Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al. 2005. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci 102: 18538-18543.
81. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD. 2001. IFNg and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111.
82. Shen TL, Park AY, Alcaraz A, Peng X, Jang I, Koni P, Flavell RA, Gu H, Guan JL. 2005. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol 169: 941-952.
83. Simonsen A, Tooze SA. 2009. Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186: 773-782.
84. Sun P, Yoshizuka N, New L, Moser BA, Li Y, Liao R, Xie C, Chen J, Deng Q, Yamout M, et al. 2007. PRAK is essential for ras-induced senescence and tumor suppression. Cell 128: 295-308.
85. Swann JB, Smyth MJ. 2007. Immune surveillance of tumors. J Clin Invest 117: 1137-1146.
86. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A. 2009. Absence of autophagy results in reactive oxygen speciesdependent amplification of RLR signaling. Proc Natl Acad Sci 106: 2770-2775.
87. Tschan MP, Simon HU. 2010. The role of autophagy in anticancer therapy: promises and uncertainties. J InternMed 268: 410-418.
88. Ueda H, Abbi S, Zheng C, Guan JL. 2000. Suppression of Pyk2 kinase and cellular activities by FIP200. J Cell Biol 149: 423-430.
89. Virgin HW, Levine B. 2009. Autophagy genes in immunity. Nat Immunol 10: 461-470.
90. Wei H, Wang X, Gan B, Urvalek AM, Melkoumian ZK, Guan JL, Zhao J. 2006. Sumoylation delimits KLF8 transcriptional activity associated with the cell cycle regulation. J Biol Chem 281: 16664-16671.
91. Wei H, Gan B, Wu X, Guan JL. 2009. Inactivation of FIP200 leads to inflammatory skin disorder, but not tumorigenesis, in conditional knock-out mouse models. J Biol Chem 284: 6004-6013.
92. White E, DiPaola RS. 2009. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 15: 5308-5316.
93. Wiseman BS, Werb Z. 2002. Stromal effects on mammary gland development and breast cancer. Science 296: 1046-1049.
94. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23: 33-42.
95. Yang Z, Klionsky DJ. 2010. Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822.
96. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, Tavare S, Arakawa S, Shimizu S, Watt FM, et al. 2009. Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
97. Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX. 2004. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 5: 141-149.
98. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. 2003. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci 100: 15077-15082.
99. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, et al. 2003. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348: 203-213.
100. Zitvogel L, Kepp O, Kroemer G. 2010. Decoding cell death signals in inflammation and immunity. Cell 140: 798-804.
101. Zou W. 2005. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5: 263-274.
102. Zou W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295-307.
103. Zou W, Restifo NP. 2010. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10: 248-256.